Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 750 of 3173 entries
View as:

Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00599924 Org: User:
Start: 09/30/05 End: 11/30/08 Due: 11/30/09

A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

Phase: N/A Priority: Normal
NCT ID: NCT06179446 Org: User:
Start: 12/13/23 End: 09/25/25 Due: 09/25/26

Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

Phase: N/A Priority: Normal
NCT ID: NCT00795639 Org: User:
Start: 12/31/08 End: 03/31/11 Due: 03/31/12

A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT06279234 Org: User:
Start: 02/20/24 End: 04/11/25 Due: 04/11/26

Korea Post Marketing Surveillance (PMS) Study of Vizimpro

Phase: N/A Priority: Normal
NCT ID: NCT04721106 Org: User:
Start: 03/07/21 End: 03/30/26 Due: 03/30/27

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00880009 Org: User:
Start: 07/30/09 End: 05/31/10 Due: 05/31/11

Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules

Phase: N/A Priority: Normal
NCT ID: NCT04967443 Org: User:
Start: 09/22/21 End: 02/15/22 Due: 02/15/23

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT03572062 Org: User:
Start: 06/05/18 End: 08/19/20 Due: 08/19/21

A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01858389 Org: User:
Start: 07/31/13 End: 09/30/15 Due: 09/30/16

Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00040014 Org: User:
Start: 06/30/02 End: 12/31/06 Due: 12/31/07

Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01757756 Org: User:
Start: 10/31/12 End: 11/30/12 Due: 11/30/13

Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00067314 Org: User:
Start: 06/30/03 End: 06/30/07 Due: 06/30/08

Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00479557 Org: User:
Start: 05/31/07 End: 01/31/13 Due: 01/31/14

A Study of Azithromycin in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002344 Org: User:
Start: - End: - Due: -

CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01653158 Org: User:
Start: 03/31/05 End: 02/28/09 Due: 02/28/10

Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00815906 Org: User:
Start: 12/31/08 End: 05/31/12 Due: 05/31/13

Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01159626 Org: User:
Start: 07/31/10 End: 11/30/10 Due: 11/30/11

Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit

Phase: N/A Priority: Normal
NCT ID: NCT00818207 Org: User:
Start: 03/31/09 End: 09/30/10 Due: 09/30/11

A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)

Phase: N/A Priority: Normal
NCT ID: NCT02616185 Org: User:
Start: 12/30/15 End: 02/23/21 Due: 02/23/22

A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.

Phase: N/A Priority: Normal
NCT ID: NCT00721422 Org: User:
Start: 08/31/08 End: 02/28/09 Due: 02/28/10

A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00741884 Org: User:
Start: 08/31/10 End: 08/31/11 Due: 08/31/12

Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.

Phase: N/A Priority: Normal
NCT ID: NCT00820742 Org: User:
Start: 02/29/08 End: 05/31/09 Due: 05/31/10

A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations

Phase: N/A Priority: Normal
NCT ID: NCT04338711 Org: User:
Start: 06/17/20 End: 09/15/20 Due: 09/15/21

Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532

Phase: N/A Priority: Normal
NCT ID: NCT01388829 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone

Phase: N/A Priority: Normal
NCT ID: NCT06113952 Org: User:
Start: 01/31/24 End: 10/17/25 Due: 10/17/26